BridgeBio Pharma BBIO
NASDAQ BBIO
$65.97 -0.64 (-0.96%)
At close: Sep 29, 2026 · 4:00 PM EDT

BridgeBio Pharma (BBIO) Revenue (2020 - 2026)

Updated

BridgeBio Pharma (BBIO) posted Revenue of $243.68 million for Q2 2026, up 120.4% from $110.57 million a year earlier and up 25.3% from the prior quarter.

Analysis

BridgeBio Pharma (BBIO) Revenue (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Revenue at BridgeBio Pharma was $713.07 million, up 202.4% year-over-year; for FY2025, it was $502.08 million, up 126.3% from FY2024.

  • Annual Revenue shows a five-year compound annual growth rate of 127.4% (FY2020 to FY2025).
  • In prior years, BridgeBio Pharma's Revenue was $221.9 million in FY2024, $9.3 million in FY2023 (-88.0%), $77.65 million in FY2022 (+11.4%) and $69.72 million in FY2021 (+745.1%).
  • The Q2 2026 figure stands as the highest quarterly Revenue in data going back to Q3 2019.
  • On a year-over-year basis, Revenue increased in three of the last five quarters, with growth averaging 69.3%.
  • The strongest year-over-year quarter for Revenue in the past five years was Q1 2022, with growth of 266.7%; the weakest was Q2 2023, with a decline of 97.8%.
  • According to Business Quant data, Revenue for the three prior quarters was $194.52 million (Q1 2026), $154.18 million (Q4 2025) and $120.7 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.31 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 16.99 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 15.38 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 7.80 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.33 Bn
10 BridgeBio Pharma 13.01 Bn 10.12 Bn 228.63 Mn 243.68 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 243.68 Mn
Mar 31, 2026 194.52 Mn
Dec 31, 2025 154.18 Mn
Sep 30, 2025 120.70 Mn
Jun 30, 2025 110.57 Mn
Mar 31, 2025 116.63 Mn
Dec 31, 2024 5.88 Mn
Sep 30, 2024 2.73 Mn
Jun 30, 2024 2.17 Mn
Mar 31, 2024 211.12 Mn
Dec 31, 2023 1.75 Mn
Sep 30, 2023 4.09 Mn
Jun 30, 2023 1.64 Mn
Mar 31, 2023 1.83 Mn
Dec 31, 2022 1.87 Mn
Sep 30, 2022 338,000.00
Jun 30, 2022 73.75 Mn
Mar 31, 2022 1.69 Mn
Dec 31, 2021 12.89 Mn
Sep 30, 2021 2.34 Mn
API Access

BridgeBio Pharma Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=BBIO&period=max&api_key=YOUR_API_KEY